| Name | PARP Inhibitor Therapy |
| Summary | Comprehensive therapeutic page for PARP inhibitors across neurodegenerative diseases including AD, PD, CBS, PSP, ALS, FTD, and Huntington's disease. Covers NAD+ depletion mechanism, DNA repair modulation, anti-inflammatory effects, clinical trial status, CNS penetration challenges, and combination a |